Skandinaviska Enskilda Banken Ab (Publ) Bio Techne Corp Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

$21.5 Billion
Q3 2024

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Bio Techne Corp stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 28,264 shares of TECH stock, worth $2.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

28,264

Previous 28,264 -0.0%

Holding current value

$2.02 Million

Previous $2.03 Million 11.51%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$65.98 - $77.09 $576,995 - $674,152	-8,745 Reduced 23.63%	28,264 $1.99 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $26,467 - $39,188	501 Added 1.37%	37,009 $2.86 Million
Q3 2023 Nov 09, 2023	SELL	$67.52 - $89.42 $4,726 - $6,259	-70 Reduced 0.19%	36,508 $2.49 Million
Q2 2023 Aug 07, 2023	BUY	$73.76 - $85.98 $214,125 - $249,599	2,903 Added 8.62%	36,578 $2.99 Million
Q1 2023 May 11, 2023	SELL	$71.62 - $86.62 $41,897 - $50,672	-585 Reduced 1.71%	33,675 $2.5 Million
Q4 2022 Feb 08, 2023	BUY	$80.67 - $352.29 $2.11 Million - $9.24 Million	26,217 Added 325.96%	34,260 $2.84 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $52,834 - $73,275	187 Added 2.38%	8,043 $2.28 Million
Q2 2022 Aug 10, 2022	SELL	$322.67 - $449.65 $359,131 - $500,460	-1,113 Reduced 12.41%	7,856 $2.72 Million
Q1 2022 May 11, 2022	SELL	$353.85 - $487.79 $576,775 - $795,097	-1,630 Reduced 15.38%	8,969 $3.88 Million
Q4 2021 Feb 10, 2022	SELL	$456.15 - $525.06 $1.23 Million - $1.42 Million	-2,701 Reduced 20.31%	10,599 $5.39 Million
Q3 2021 Nov 10, 2021	SELL	$444.87 - $538.88 $310,964 - $376,677	-699 Reduced 4.99%	13,300 $6.45 Million
Q2 2021 Aug 10, 2021	BUY	$387.35 - $450.26 $5.07 Million - $5.9 Million	13,099 Added 1455.44%	13,999 $6.3 Million
Q1 2021 May 14, 2021	BUY	$314.62 - $411.0 $31,462 - $41,100	100 Added 12.5%	900 $344,000
Q4 2020 Feb 11, 2021	BUY	$246.9 - $321.87 $197,520 - $257,496	800 New	800 $254,000
Q2 2019 Aug 09, 2019	SELL	$188.72 - $215.43 $1.04 Million - $1.18 Million	-5,500 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$136.09 - $200.44 $3.72 Million - $5.47 Million	-27,300 Reduced 83.23%	5,500 $1.09 Million
Q4 2018 Feb 12, 2019	BUY	$132.75 - $203.8 $4.35 Million - $6.68 Million	32,800 New	32,800 $4.75 Million
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $3.77 Million - $4.31 Million	-26,000 Closed	0 $0
Q1 2018 Apr 30, 2018	SELL	$131.46 - $151.04 $723,030 - $830,720	-5,500 Reduced 17.46%	26,000 $3.93 Million
Q4 2017 Feb 12, 2018	SELL	$121.17 - $134.75 $908,775 - $1.01 Million	-7,500 Reduced 19.23%	31,500 $4.08 Million
Q2 2017 Aug 14, 2017	BUY	N/A	39,000	39,000 $0

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Account

Skandinaviska Enskilda Banken Ab (Publ) Bio Techne Corp Transaction History